The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders.

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Advances in neurobiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/978-3-031-21054-9_3PMID 36928846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NAc-VTA circuit underlies emotional stress-induced anxiety-like behavior in the three-chamber vicarious social defeat stress mouse model

  2022cited by this paper
• The effectiveness of (R)-ketamine and its mechanism of action differ from those of (S)-ketamine in a chronic unpredictable mild stress model of depression in C57BL/6J mice.

  2021cited by this paper
• Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood

  2021cited by this paper
• Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology

  2021cited by this paper
• Prefrontal contributions to action control in rodents.

  2021cited by this paper
• Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials

  2021cited by this paper
• The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain

  2021cited by this paper
• Use of mouse models to investigate the contributions of CNVs associated with schizophrenia and autism to disease mechanisms.

  2021cited by this paper
• Fluoxetine and environmental enrichment similarly reverse chronic social stress-related depression- and anxiety-like behavior, but have differential effects on amygdala gene expression

  2021cited by this paper
• Right frontal anxiolytic-sensitive EEG ‘theta’ rhythm in the stop-signal task is a theory-based anxiety disorder biomarker

  2021cited by this paper
• Diazepam effects on local cortical neural activity during sleep in mice

  2021cited by this paper
• Combinatorial PharmacogenomicTesting Improves Outcomes for Older Adults With Depression.

  2020cited by this paper
• The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders

  2020cited by this paper
• Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options

  2020cited by this paper
• The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research

  2020cited by this paper
• Rodent models of post-traumatic stress disorder: behavioral assessment

  2020cited by this paper
• The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey

  2020cited by this paper
• Naltrexone attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.

  2020cited by this paper
• Cognition- and circuit-based dysfunction in a mouse model of 22q11.2 microdeletion syndrome: effects of stress

  2020cited by this paper
• A Review of Behavioral Tests to Evaluate Different Types of Anxiety and Anti-anxiety Effects

  2020cited by this paper
• Rodent models for psychiatric disorders: problems and promises

  2020cited by this paper
• Two novel mouse models mimicking minor deletions in 22q11.2 deletion syndrome revealed the contribution of each deleted region to psychiatric disorders

  2020cited by this paper
• Predicting susceptibility and resilience in an animal model of post-traumatic stress disorder (PTSD)

  2020cited by this paper
• Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review

  2020cited by this paper
• Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers

  2020cited by this paper
• Justification for species selection for pharmaceutical toxicity studies

  2020cited by this paper
• Translating insights from neuropsychiatric genetics and genomics for precision psychiatry

  2020cited by this paper
• Baclofen and naltrexone, but not N-acetylcysteine, affect voluntary alcohol drinking in rats regardless of individual levels of alcohol intake

  2020cited by this paper
• A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia.

  2020cited by this paper
• Chronic postnatal chemogenetic activation of forebrain excitatory neurons evokes persistent changes in mood behavior

  2020cited by this paper
• Establishing operant conflict tests for the translational study of anxiety in mice

  2019cited by this paper
• Esketamine and rapastinel, but not imipramine, have antidepressant-like effect in a treatment-resistant animal model of depression

  2019cited by this paper
• PI3K/Akt/NF‐&kgr;B signaling pathway regulates behaviors in adolescent female rats following with neonatal maternal deprivation and chronic mild stress

  2019cited by this paper
• Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.

  2019cited by this paper
• What do we know about sex differences in depression: A review of animal models and potential mechanisms

  2019cited by this paper
• Dissociable dopamine dynamics for learning and motivation.

  2019cited by this paper
• Indirect Medium Spiny Neurons in the Dorsomedial Striatum Regulate Ethanol-Containing Conditioned Reward Seeking

  2019cited by this paper
• Predator stress-induced depression is associated with inhibition of hippocampal neurogenesis in adult male mice

  2019cited by this paper
• Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders.

  2019cited by this paper
• Animal models of major depression: drawbacks and challenges

  2019cited by this paper
• Fluorescent Biosensors for Neurotransmission and Neuromodulation: Engineering and Applications

  2019cited by this paper
• Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.

  2019cited by this paper
• Depression and Sleep

  2019cited by this paper
• SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action

  2019cited by this paper
• Single-Prolonged Stress Impairs Prefrontal Cortex Control of Amygdala and Striatum in Rats

  2019cited by this paper
• Defining treatment‐resistant depression

  2019cited by this paper
• Mapping optogenetically-driven single-vessel fMRI with concurrent neuronal calcium recordings in the rat hippocampus

  2019cited by this paper
• Unmet mental health and substance use treatment needs among older homeless adults: Results from the HOPE HOME Study.

  2019cited by this paper
• Ultrafast neuronal imaging of dopamine dynamics with designed genetically encoded sensors

  2018cited by this paper
• CRISPR/Cas9-mediated disruption of SHANK3 in monkey leads to drug-treatable autism-like symptoms

  2018cited by this paper
• Meeting Report: Can We Make Animal Models of Human Mental Illness?

  2018cited by this paper
• Alteration in NMDA Receptor Mediated Glutamatergic Neurotransmission in the Hippocampus During Senescence

  2018cited by this paper
• Treatment strategies for ADHD: an evidence-based guide to select optimal treatment

  2018cited by this paper
• The Lancet Commission on global mental health and sustainable development.

  2018cited by this paper
• Animal models of PTSD: a challenge to be met

  2018cited by this paper
• Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review

  2018cited by this paper
• In vivo widefield calcium imaging of the mouse cortex for analysis of network connectivity in health and brain disease

  2018cited by this paper
• Advantages of the Alpha-lipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced by Ketamine in Rats: Behavioral and Oxidative Stress evidences.

  2018cited by this paper
• Neurobiology and consequences of social isolation stress in animal model-A comprehensive review.

  2018cited by this paper
• Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review

  2018cited by this paper
• Mouse Cre-LoxP system: general principles to determine tissue-specific roles of target genes

  2018cited by this paper
• The anxiolytic-like effects of estazolam on a PTSD animal model.

  2018cited by this paper
• Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial

  2018cited by this paper
• Optogenetic Tools for Subcellular Applications in Neuroscience.

  2017cited by this paper
• Animal models in psychiatric research: The RDoC system as a new framework for endophenotype-oriented translational neuroscience

  2017cited by this paper
• Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice

  2017cited by this paper
• Differential gene expression profiles in neurons generated from lymphoblastoid B-cell line-derived iPS cells from monozygotic twin cases with treatment-resistant schizophrenia and discordant responses to clozapine.

  2017cited by this paper
• Behavioral methods to study anxiety in rodents

  2017cited by this paper
• Pattern of c-Fos expression induced by tail suspension test in the mouse brain

  2017cited by this paper
• Effect of post-weaning isolation on anxiety- and depressive-like behaviors of C57BL/6J mice

  2017cited by this paper
• The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes

  2017cited by this paper
• Group and Individual Variability in Mouse Pup Isolation Calls Recorded on the Same Day Show Stability

  2017cited by this paper
• C. elegans as Model for Drug Discovery.

  2017cited by this paper
• Study of Sex Differences in Duloxetine Efficacy for Depression in Transgenic Mouse Models

  2017cited by this paper
• Altered neurogenesis and disrupted expression of synaptic proteins in prefrontal cortex of SHANK3-deficient non-human primate

  2017cited by this paper
• Abuse-related effects of subtype-selective GABAA receptor positive allosteric modulators in an assay of intracranial self-stimulation in rats

  2017cited by this paper
• The translational relevance of Drosophila in drug discovery

  2016cited by this paper
• Chronic unpredictable mild stress paradigm in male Wistar rats: effect on anxiety- and depressive-like behavior.

  2016cited by this paper
• Epigenetic regulation of BDNF in the learned helplessness-induced animal model of depression.

  2016cited by this paper
• Sex Differences in Effects of Ketamine on Behavior, Spine Density, and Synaptic Proteins in Socially Isolated Rats.

  2016cited by this paper
• Antidepressant imipramine diminishes stress-induced inflammation in the periphery and central nervous system and related anxiety- and depressive- like behaviors.

  2016cited by this paper
• Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.

  2016cited by this paper
• PTSD Treatment for Veterans: What's Working, What's New, and What's Next.

  2016cited by this paper
• Paroxetine treatment, following behavioral suppression of PTSD-like symptoms in mice, prevents relapse by activating the infralimbic cortex.

  2016cited by this paper
• Animal models of major depression and their clinical implications.

  2016cited by this paper
• The forced swim test as a model of depressive-like behavior.

  2015cited by this paper
• DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility.

  2015cited by this paper
• Adolescent social isolation increases anxiety-like behavior and ethanol intake and impairs fear extinction in adulthood: Possible role of disrupted noradrenergic signaling.

  2015cited by this paper
• Highthroughtput analysis of behavior for drug discovery

  2015cited by this paper
• Research Domain Criteria: toward future psychiatric nosologies

  2015cited by this paper
• Memory impairment and alterations in prefrontal cortex gamma band activity following methamphetamine sensitization

  2015cited by this paper
• The many different faces of major depression: it is time for personalized medicine.

  2015cited by this paper
• Effects of paroxetine on PTSD-like symptoms in mice

  2015cited by this paper
• Illuminating circuitry relevant to psychiatric disorders with optogenetics.

  2015cited by this paper
• International Union of Basic and Clinical Pharmacology. XCVII. G Protein–Coupled Estrogen Receptor and Its Pharmacologic Modulators

  2015cited by this paper
• Comparison of the validity of the use of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder in males and females.

  2015cited by this paper
• Modeling psychiatric disorders for developing effective treatments

  2015cited by this paper
• Escalation of cocaine consumption in short and long access self-administration procedures.

  2015cited by this paper
• The CRF₁ receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: comparison with paroxetine and d-cycloserine.

  2015cited by this paper
• A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbances.

  2015cited by this paper

• No citing papers are available for this paper.